Visit the ASCO 2022 widget for updates on data being presented at this event.

Top Stories
Addition of Atezolizumab to FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer

The addition of atezolizumab to FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, irinotecan) and bevacizumab improved progression-free survival in the first-line treatment of patients with metasta

The ASCO Post
1w ago
Length of Stay and Cost of Care Associated With Admissions for Atrial Fibrillation Among Patients With Cancer

The aim of this study is to assess the burden of AF-related hospitalizations inclusive of inflation-adjusted cost-of-care and length-of-stay (LOS) among cancer patients and the impact of direct cur

BMC Cardiovascular Disorders
1w ago
Adaptation to Bortezomib Treatment in Multiple Myeloma Cells

Researchers characterized possible features of multiple myeloma (MM) cells that may be related to bortezomib (BTZ) resistance in patients with MM, in a new study published in the journal Cell D

Hematology Advisor
1w ago
Medical Graph


The ASCO Post

Medicaid expansion under the Affordable Care Act (ACA) was associated with an increase in 2-year overall survival rates among patients newly diagnosed with cancer...

Lung Cancer
Aggrego Oncology - 3/24/22
Aggrego Oncology
3m ago
Aggrego Pulse - 10/07/21
Aggrego Oncology
8m ago
Hematologic Malignancies